ReviewJACC. CardioOncology2024

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Preclinical Cardiotoxicity Screening in Cardio-Oncology.

Kyle D Shead et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.